NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 19, 2026 — MindBio Therapeutics introduces world-first voice-based AI system for drug and alcohol impairment detection, targeting mining and other high-risk industries. Learn how voice analysis enhances safety.
May 19, 2026 — Quantum BioPharma (QNTM) reports midpoint enrollment in MS imaging study with Massachusetts General Hospital, showing encouraging PET tracer data for demyelination, boosting Lucid-MS development.
May 19, 2026 — Cardio Diagnostics Holdings (CDIO) uses AI, epigenetics, and genetics to prevent cardiovascular disease. Learn how their Epi+Gen CHD and PrecisionCHD solutions aim to reduce CVD deaths.
May 19, 2026 — American Heart Association's 2026 Dietary Guidance offers 9 key features to improve cardiovascular health, focusing on whole foods, reducing sodium and sugar, and limiting alcohol. Learn more.
May 19, 2026 — Actually Sleeping pediatric sleep consultancy helps 100+ families achieve 12-hour nights with science-backed, personalized plans for infants and toddlers. Learn how to transform your household.
May 19, 2026 — Oragenics (OGEN) to present at Sidoti Micro-Cap Virtual Conference on May 21, 2026. Learn about its intranasal delivery platform and ONP-002 for concussion.
May 19, 2026 — Single-payer healthcare gains traction in Massachusetts as affordability crisis drives grassroots movements, potentially reshaping U.S. health insurance landscape.
May 19, 2026 — Datavault AI (NASDAQ: DVLT) signs exclusive licensing deal with Wellgistics Health to deploy PharmacyChain platform, targeting PBM-driven drug pricing inefficiencies. Learn how this AI solution aims to lower costs.
May 19, 2026 — NanoViricides closes $2M offering to fund NV-387, a broad-spectrum antiviral targeting COVID-19, RSV, and influenza. Learn about the company's pipeline and technology.
May 19, 2026 — CEL-SCI completes $7.2M public offering for Multikine development, a neoadjuvant immunotherapy for head and neck cancer. Learn about CVM stock and the potential impact on cancer treatment.
May 19, 2026 — LataMed AI Corp. highlights a planned emergency medical response feature using geolocation to connect users with nearby ambulance providers, clinics, and hospitals, aiming to improve emergency coordination in emerging markets.
May 19, 2026 — Lantern Pharma receives FDA no objections for LP-300 Phase 2 HARMONIC trial amendments, focusing on EGFR L858R-mutant never-smokers with lung cancer.
May 19, 2026 — Anh Phoong, a Sacramento attorney, wins the 2026 National Woman of Impact award from the American Heart Association’s Go Red for Women movement, raising awareness about cardiovascular disease as the leading cause of death in women.
May 19, 2026 — Tampa Bay teen Leonardo Oliveira wins 2026 National Teen of Impact from American Heart Association for nutrition advocacy, fighting heart disease and stroke in youth.
May 19, 2026 — BFCH closes acquisition of Ancient Extracts USA wellness platform, adding 20+ SKUs and DTC infrastructure. CEO Gorst says the move de-risks strategy and positions for retail expansion and long-term growth.
May 19, 2026 — A smart-technology wristband detected cardiac arrest with 92% accuracy in a study published in Circulation: Arrhythmia and Electrophysiology. The DETECT-1b study validates an algorithm for real-world use, potentially saving lives by alerting emergency services.
May 18, 2026 — Viromed Medical AG partners with NEBU-TEC to distribute PulmoPlas® cold plasma technology for veterinary respiratory diseases, targeting equine market with innovative nebulization solutions.
May 18, 2026 — GeoVax stresses importance of scalable U.S.-based vaccine manufacturing amid WHO Ebola emergency and mpox spread. GEO-MVA mpox/smallpox vaccine advances with Phase 3 trial planned for 2026.
May 18, 2026 — Sino Biological launches XPressMAX™ Cell-Free Protein Synthesis Kit for ultra-fast antibody synthesis in 3 hours, accelerating AI-driven high-throughput screening for drug discovery.
May 18, 2026 — Cardio Diagnostics (NASDAQ: CDIO) uses AI, epigenetics, and genetics to pioneer personalized heart care, shifting from reactive treatment to predictive prevention for cardiovascular disease.